Completed NA NCT01044095

Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus

Evaluation of In Vitro Cross-Reactivity With Avian Influenza H5N1 Virus in Healthy Volunteers Vaccinated With a Prime Boost Regimen of Seasonal Influenza Vaccine

Sponsor: Armed Forces Research Institute of Medical Sciences, Thailand

Conditions Influenza

Interventions FluMist® live, attenuated, intranasal seasonal influenza vaccine Fluzone® inactivated influenza virus vaccine

Updated 5 times since 2017 Last updated: Jul 22, 2013 Started: Nov 30, 2009 Primary completion: Jul 31, 2010 Completion: Jun 30, 2012

Listed as NCT01044095, this NA trial focuses on Influenza and remains completed. Sponsored by Armed Forces Research Institute of Medical Sciences, Thailand, it has been updated 5 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Armed Forces Research Institute of Medical Sciences, Thailand

Data source: Armed Forces Research Institute of Medical Sciences, Thailand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand